iRhythm Technologies, Inc. (IRTC) News
Filter IRTC News Items
IRTC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
IRTC News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest IRTC News From Around the Web
Below are the latest news stories about IRHYTHM TECHNOLOGIES INC that investors may wish to consider to help them evaluate IRTC as an investment opportunity.
3 Undervalued US Stocks Estimated To Be Up To 30.8% Below Intrinsic ValueAs the U.S. stock market wraps up a strong year with a slight downturn, major indices like the Dow Jones Industrial Average and S&P 500 have experienced notable monthly losses despite impressive annual gains. In this context of fluctuating performance, identifying undervalued stocks becomes crucial for investors aiming to capitalize on potential market inefficiencies and intrinsic value discrepancies. |
iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceSAN FRANCISCO, Dec. 30, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the company will be participating in the upcoming 43rd Annual J.P. Morgan Healthcare Conference. iRhythm’s management is scheduled to present on Monday, January 13, 2025, at 4:30 p.m. Pacific Time/7:30 p.m. Eastern Time. Interested parties may access a live and archived web |
iRhythm price target raised to $111 from $85 at TruistTruist raised the firm’s price target on iRhythm (IRTC) to $111 from $85 and keeps a Buy rating on the shares as part of a broader research note previewing 2025 in Medical Technology. The firm sees the sector as “one of the better/safer houses” in healthcare given its lower “front-line” exposure to healthcare policy rhetoric that is tied to the administration change as well as its position as an “innovation segment” with sustainable above-average revenue and EPS growth, strong balance sheets, an |
iRhythm Technologies to Participate in the Citi 2024 Global Healthcare ConferenceSAN FRANCISCO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company will be participating in the upcoming Citi 2024 Global Healthcare Conference. iRhythm’s management is scheduled to participate in a fireside chat on Wednesday, December 4, 2024, at 10:15 am Eastern Time. Interested parties may access a live and archived web |
Inside a $400 billion bet on the brain-computer interface revolutionMorgan Stanley's latest report pegs the BCI market at $400 billion — signaling to investors that this revolutionary technology is the next big bet in medtech. |
iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous MonitoringFive new studies span three focus areas for LTCM devices: digital engagement and patient satisfaction, arrhythmia patterns during sleep and activity, and the potential health care resource and economic impact of early arrhythmia detection in patients with type 2 diabetes and COPDSAN FRANCISCO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced the results of five new studies presented at the American Heart Association’s 2024 Scientific Sessions in Chicago, |
iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare ConferenceSAN FRANCISCO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company will be participating in the upcoming Wolfe Research 2024 Healthcare Conference. iRhythm’s management is scheduled to participate in a fireside chat on Tuesday, November 19, at 9:50 am Eastern Time. Interested parties may access a live and archived webcast |
Here’s Why iRhythm Technologies (IRTC) Slid in Q3Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund appreciated 5.81%% (Institutional Shares) in the quarter compared to a 6.74% gain for the Russell 3000 Health Care Index (benchmark) and a 6.23% gain for the Russell […] |
iRhythm Technologies, Inc. (NASDAQ:IRTC) Just Reported, And Analysts Assigned A US$101 Price TargetLast week, you might have seen that iRhythm Technologies, Inc. ( NASDAQ:IRTC ) released its quarterly result to the... |
FDA clears iRhythm’s second 510(k) in response to warning letterHowever, the company said it will delay a submission for its next-generation Zio cardiac monitoring system until remediation efforts are further along. |